Oncology Nursing News®

Register for a live webcast-"A New CD38-Directed Antibody for the Treatment of Appropriate Relapsed Refractory Multiple Myeloma Patients"

Gynecologic Cancers

PARP Inhibitors Show Promise in Treating Patients with Ovarian Cancer

PARP Inhibitors Show Promise in Treating Patients with Ovarian Cancer

BY CAROLINE SEYMOUR

African American Women Aren't Receiving the Benefits of Breast Cancer Awareness

African American Women Aren't Receiving the Benefits of Breast Cancer Awareness

BY KAREN HARRIS, MSN, RN

FDA Approves Niraparib For Patients With HRD+ Advanced Ovarian Cancer

FDA Approves Niraparib For Patients With HRD+ Advanced Ovarian Cancer

BY GINA COLUMBUS

Expert Weighs In On The Future of PARP Inhibitors

Expert Weighs In On The Future of PARP Inhibitors

BY BHAVANA POTHURI, MD

Frontline Combo Therapy Shows Improved Results for Ovarian Cancer Treatment

Frontline Combo Therapy Shows Improved Results for Ovarian Cancer Treatment

BY SILAS INMAN

Study Shows Niraparib Extends Time Without Symptoms, Toxicity in Ovarian Cancer

Study Shows Niraparib Extends Time Without Symptoms, Toxicity in Ovarian Cancer

BY SETH AUGENSTEIN

FDA Approves Combination of Lenvatinib and Pembrolizumab For Advanced Endometrial Carcinoma Treatment

FDA Approves Combination of Lenvatinib and Pembrolizumab For Advanced Endometrial Carcinoma Treatment

BY GINA COLUMBUS

Establishing Medical Fitness is the First Step in Treating Patients with Advanced Ovarian Cancer

Establishing Medical Fitness is the First Step in Treating Patients with Advanced Ovarian Cancer

BY CAROLINE SEYMOUR

The Treatment Landscape for Recurrent Ovarian Cancer Is Evolving

The Treatment Landscape for Recurrent Ovarian Cancer Is Evolving

BY CAROLINE SEYMOUR

New USPSTF BRCA Recommendations Still Fall Short

New USPSTF BRCA Recommendations Still Fall Short

BY BRIELLE BENYON

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc

OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.